Geneon Lab Testing Reports: Table 1

GenEon Lab Testing Reports
Table 1.
The virucidal efficacy of the solution generated by the provided Trio RX Unit (BCS1402294) unit
against Human herpesvirus 1 Virus. Test was conducted as per AOAC Official Method 961.02;
Germicidal Spray Products as Disinfectants (2005) and ASTM E1053 Standard Test Method for
Efficacy of Virucidal Agents Intended for Inanimate Environmental Surfaces. Free Available
Chlorine: 530ppm at pH 7.0. Viruses are enumerated by cell culture as Infectious Units (IU).
16026 University Oak, San Antonio, TX 78249
sales@geneontechnologies.com
866.217.0205
Table 2.
The bactericidal
efficacy
of the liquid
generated
by GenEons On-Site
Generators; Germicidal Spray Products as Disinfectants (2005) using a 30 second contact time
with a ppm of between 350-380.
Number of
Sprayed
Inoculated Slides
(number of
replicates tested)
Average
microorganism
cfu/mL
inoculated per
slide#
Average
cfu/mL
recovered from
each of slides
sprayed*
Bacteriophage
MS-2
2.4 x 105
< .91
>99.9996%
>5.4
Pseudomonas
aeruginosa
3.0 x 105
< .91
>99.9997%
>5.5
Microorganism
Percent
Reduction
Log10
reduction
BCS Laboratories, Inc. - Gainesville
4609 NW 6th Street, Ste A, Gainesville, Florida 32609

Tel. (352) 377-9272, Fax. (352) 377-5630
www.microbioservices.com
FL DOH Laboratory #E82924, EPA# FL01147
File: Geneon Human HIV -poliovirus virucidal efficacy BCS 1411090 December 5 2014.doc
This report shall not be reproduced, except in full, without the written consent of BCS Laboratories.
Table 3.
The virucidal efficacy of the solution generated by the provided Trio RX Unit (BCS1402294) unit against Human Poliovirus 1 (CHAT) in a
protein load inoculum. Test was conducted as per AOAC Official Method 961.02; Germicidal Spray Products as Disinfectants (2005) and
ASTM E1053 Standard Test Method for Efficacy of Virucidal Agents Intended for Inanimate Environmental Surfaces. Free Available Chlorine:
500ppm at pH 7.0. Viruses are enumerated as Infectious Units (IU). Poliovirus served as a model for Human Immunodeficiency Virus (HIV)
inactivation*
Microorganism
Number of
replicates
tested
Human Poliovirus 1
VR 1562
Contact
Time
(minutes)
Average iu/mL
Average iu/mL
Average
Percent
Recovered From
Recovered From
Percent
Reduction
Control Slides# Each Sprayed Slide*
Reduction
0.5
3.1 x 104
56
99.8%
46
99.9%
68
99.8%
16
99.95%
12
99.96%
12
99.96%
0.4
99.999%
1.2
99.996%
2.2
99.993%

Tel. (352) 377-9272, Fax. (352) 377-5630
File: Geneon Human HIV -poliovirus virucidal efficacy BCS 1411090 December 5 2014.doc
Log10
reduction
99.8%
2.7
99.96%
3.4
99.996%
4.6
Table 4. The virucidal efficacy of the solution generated by the provided Trio RX Unit (BCS1402294) unit against Bovine
Diarrhea Virus 1. Test was conducted as per AOAC Official Method 961.02; Germicidal Spray Products as Disinfectants (2005)
and ASTM E1053 Standard Test Method for Efficacy of Virucidal Agents Intended for Inanimate Environmental Surfaces. Free
Available Chlorine: 510 ppm at pH 6.77. Viruses are enumerated by cell culture as Infectious Units (IU).
Microorganism
Number of
replicates
tested
Bovine Diarrhea
Virus 1
VR-534
Contact
Average iu/mL
Average iu/mL
Average
Percent
Time
Recovered From
Recovered From
Percent
Reduction
(Seconds) Control Slides# Each Sprayed Slide*
Reduction
30
60
180
2.9 x 103
0.5
99.98%
0.8
99.97%
0.5
99.98%
<0.2
>99.994%
<0.2
>99.994%
<0.2
>99.994%
<0.2
>99.994%
<0.2
>99.994%
<0.2
>99.994%

Tel. (352) 377-9272, Fax. (352) 377-5630
File: Geneon HSV-1, Enterovirus 69, and BDV virucidal efficacy BCS1402294 December 5 2014.doc
Log10
reduction
99.98%
3.7
>99.994%
>4.2
>99.994%
>4.2
Table 5. The virucidal efficacy of Trio RX unit (BCS1411090) generated solution against Human Poliovirus 1 (CHAT)
suspension following a 30 second contact. Test was conducted as per ASTM E1052 Standard Test Method for
Efficacy of Antimicrobial Agents Against Viruses in Suspension. Free Available Chlorine: 1268ppm. Viruses are
enumerated as Infectious Units (IU). Poliovirus served as a model for Human Immunodeficiency Virus (HIV) inactivation*
Microorganism
Human
Poliovirus 1
ATCC VR 1562
Number of
replicates
tested
Contact Time
(seconds)
30
Average iu/mL
Average iu/mL
Recovered From Recovered From Each
Control Slides#
Sprayed Slide*
7.7 x 105
Percent
Reduction
< 1.0
> 99.9998%
< 1.0
> 99.9998%
< 1.0
> 99.9998%

Tel. (352) 377-9272, Fax. (352) 377-5630
File: Geneon 30 second virucidal efficacy BCS 1411090 April 01 2015.doc

Average
Percent
Reduction
Log10
reduction
> 99.9998%
> 5.6
Table 5. The virucidal efficacy of Trio RX unit (BCS1411090) generated solution against Murine Norovirus MNV-1 suspension
following a 30 second contact period. Test was conducted as per ASTM E1052 Standard Test Method for Efficacy of Antimicrobial
Agents Against Viruses in Suspension. Free Available Chlorine: 1224 ppm. Viruses are enumerated as Infectious Units (IU).
Norovirus served as a model for Hepatitis B virus*
Microorganism
Murine
Norovirus 1
ATCC PTA-5935
Number of
replicates
tested
Average iu/mL
Average iu/mL
Contact Time
Recovered From Recovered From
(seconds)
30
2.3 x 105
Percent
Reduction
0.2
99.99992%
0.5
99.9998%
1.1
99.99995%

Tel. (352) 377-9272, Fax. (352) 377-5630

Average
Percent
Reduction
Log10
reduction
99.9997%
5.6
Table 6. The virucidal efficacy of Trio RX unit (BCS1411090) generated solution against Bovine Diarrhea Virus suspension following
a 30 second contact. Test was conducted as per ASTM E1052 Standard Test Method for Efficacy of Antimicrobial Agents Against
Viruses in Suspension. Free Available Chlorine: 1264ppm. Viruses are enumerated as Infectious Units (IU). Bovine Diarrhea Virus
served as a surrogate for Hepatitis C virus as per the US EPA protocols*
Microorganism
Bovine Diarrhea
Virus
ATCC VR-534
Number of
replicates
tested
Average iu/mL
Average iu/mL
Contact Time
(seconds)
30
7.3 x 104
Percent
Reduction
<0.2
>99.99997%
<0.2
>99.99997%
<0.2
>99.99997%

Tel. (352) 377-9272, Fax. (352) 377-5630

Average
Percent
Reduction
Log10
reduction
>99.9997%
>5.6
Table 7. The virucidal efficacy of Trio RX unit (BCS1411090) generated solution against Human Herpesvirus 1 (HSV)
suspension following a 30 second contact. Test was conducted as per ASTM E1052 Standard Test Method for Efficacy of Antimicrobial
Agents Against Viruses in Suspension. Free Available Chlorine: 1264ppm. Viruses are enumerated as Infectious Units (IU).
Microorganism
Human
Herpesvirus 1
ATCC VR-733
Number of
replicates
tested
Average iu/mL
Average iu/mL
Contact Time
(seconds)
30
1.3 x 105
Percent
Reduction
<1.0
>99.99992%
<1.0
>99.99992%
<1.0
>99.99992%

Tel. (352) 377-9272, Fax. (352) 377-5630

Average
Percent
Reduction
Log10
reduction
>99.9992%
>5.1
Table 8. The mycobacteriocidal efficacy of the liquid generated by the provided Trio RX (BCS1403223)1 at 30 second
contact
time at 412 ppm.
Challenge
Average
Mycobacterium
terrea cfu/mL
inoculated per
slide#
Average cfu/mL
recovered from
each of slides
sprayed*
Slide 1
<0.45
Slide 2
<0.45
Slide 3
1.9 x 106
12.7
Slide 4
<0.45
Slide 5
<0.45
Cumulative
Percent
Reduction
Cumulative
Log10 reduction
> 99.9998%
> 5.8

Tel. (352) 377-9272, Fax. (352) 377-5630
File: Trio RX Disinfectant 961 02 Mycobacterium terrea time kill report 06 26 2014 draft.doc
Table 9. The mycobacteriocidal efficacy of the liquid generated by the provided Trio RX (BCS1403223)1 at 60 second contact time
Challenge
Average
Mycobacterium
terrea cfu/mL
inoculated per
slide#
Average cfu/mL
recovered from
each of slides
sprayed*
Slide 1
<0.45
Slide 2
<0.45
Slide 3
1.9 x 106
5.0
Slide 4
0.45
Slide 5
0.45
Cumulative
Percent
Reduction
Cumulative
Log10 reduction
> 99.9999%
> 6.2

Tel. (352) 377-9272, Fax. (352) 377-5630
Challenge
Average
Mycobacterium
terrea cfu/mL
inoculated per
slide#
Average cfu/mL
recovered from
each of slides
sprayed*
Slide 1
<0.45
Slide 2
<0.45
Slide 3
1.9 x 106
0.45
Slide 4
20.0
Slide 5
<0.45
Cumulative
Percent
Reduction
Cumulative
Log10 reduction
> 99.9998%
> 5.7

Tel. (352) 377-9272, Fax. (352) 377-5630
Challenge
Average
Mycobacterium
terrea cfu/mL
inoculated per
slide#
Average cfu/mL
recovered from
each of slides
sprayed*
Slide 1
<0.45
Slide 2
0.9
Slide 3
1.9 x 106
<0.45
Slide 4
NA**
Slide 5
NA**
Cumulative
Percent
Reduction
Cumulative
Log10 reduction
> 99.9999%
> 6.5

Tel. (352) 377-9272, Fax. (352) 377-5630

Geneon Lab Testing Reports: Table 1

Hochgeladen von

Dokumentinformationen

Originalbeschreibung:

Originaltitel

Copyright

Verfügbare Formate

Dieses Dokument teilen

Dokument teilen oder einbetten

Freigabeoptionen

Stufen Sie dieses Dokument als nützlich ein?

Sind diese Inhalte unangemessen?

Copyright:

Verfügbare Formate

Geneon Lab Testing Reports: Table 1

Hochgeladen von

Copyright:

Verfügbare Formate

GenEon Lab Testing Reports

16026 University Oak, San Antonio, TX 78249

BCS Laboratories, Inc. - Gainesville

4609 NW 6th Street, Ste A, Gainesville, Florida 32609

BCS Laboratories, Inc. - Gainesville

4609 NW 6th Street, Ste A, Gainesville, Florida 32609

BCS Laboratories, Inc. - Gainesville

4609 NW 6th Street, Ste A, Gainesville, Florida 32609

BCS Laboratories, Inc. - Gainesville

4609 NW 6th Street, Ste A, Gainesville, Florida 32609

File: Geneon 30 second virucidal efficacy BCS 1411090 April 01 2015.doc

BCS Laboratories, Inc. - Gainesville

4609 NW 6th Street, Ste A, Gainesville, Florida 32609

File: Geneon 30 second virucidal efficacy BCS 1411090 April 01 2015.doc

BCS Laboratories, Inc. - Gainesville

4609 NW 6th Street, Ste A, Gainesville, Florida 32609

File: Geneon 30 second virucidal efficacy BCS 1411090 April 01 2015.doc

BCS Laboratories, Inc. - Gainesville

4609 NW 6th Street, Ste A, Gainesville, Florida 32609

File: Geneon 30 second virucidal efficacy BCS 1411090 April 01 2015.doc

BCS Laboratories, Inc. - Gainesville

4609 NW 6th Street, Ste A, Gainesville, Florida 32609

BCS Laboratories, Inc. - Gainesville

4609 NW 6th Street, Ste A, Gainesville, Florida 32609

BCS Laboratories, Inc. - Gainesville

4609 NW 6th Street, Ste A, Gainesville, Florida 32609

BCS Laboratories, Inc. - Gainesville

4609 NW 6th Street, Ste A, Gainesville, Florida 32609

Das könnte Ihnen auch gefallen